These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35151034)

  • 41. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.
    Erskine D; Ding J; Thomas AJ; Kaganovich A; Khundakar AA; Hanson PS; Taylor JP; McKeith IG; Attems J; Cookson MR; Morris CM
    Mov Disord; 2018 Jul; 33(6):982-991. PubMed ID: 29570843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
    Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic criteria of diffuse Lewy body disease].
    Mizutani T
    Nihon Rinsho; 2000 Oct; 58(10):2044-8. PubMed ID: 11068444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dementia with Lewy bodies.
    Mayo MC; Bordelon Y
    Semin Neurol; 2014 Apr; 34(2):182-8. PubMed ID: 24963677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference?
    Seppi K; Rascol O
    Neurology; 2007 Aug; 69(8):717-8. PubMed ID: 17709701
    [No Abstract]   [Full Text] [Related]  

  • 48. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
    Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients.
    Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T
    Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dementia with Lewy bodies: neuropathology.
    Dickson DW
    J Geriatr Psychiatry Neurol; 2002; 15(4):210-6. PubMed ID: 12489917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
    Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
    Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies.
    Delli Pizzi S; Maruotti V; Taylor JP; Franciotti R; Caulo M; Tartaro A; Thomas A; Onofrj M; Bonanni L
    Cortex; 2014 Oct; 59():12-21. PubMed ID: 25113955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and neuropathological correlates of dementia with Lewy bodies.
    Gómez-Tortosa E; Irizarry MC; Gómez-Isla T; Hyman BT
    Ann N Y Acad Sci; 2000; 920():9-15. PubMed ID: 11193181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders.
    Saito Y; Shioya A; Sano T; Sumikura H; Murata M; Murayama S
    Mov Disord; 2016 Jan; 31(1):135-8. PubMed ID: 26748832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia.
    Aarsland D; Ballard C; Larsen JP; McKeith I
    Int J Geriatr Psychiatry; 2001 May; 16(5):528-36. PubMed ID: 11376470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.